Search results
Results From The WOW.Com Content Network
Amniocentesis has traditionally been performed to assess the extent of fetal lung development in the context of medical and obstetrical complications, with the intention of delivering the fetus if fetal lung maturity is demonstrated. [9] Lack of fetal lung maturity increases the risk of infant respiratory distress syndrome. [10]
The lecithin–sphingomyelin ratio is a marker of fetal lung maturity. The outward flow of pulmonary secretions from the fetal lungs into the amniotic fluid maintains the level of lecithin and sphingomyelin equally until 32–33 weeks gestation, when the lecithin concentration begins to increase significantly while sphingomyelin remains nearly the same.
One main test that is performed on amniotic fluid is the L/S ratio test (lecithin/sphingomyelin). This test is used to determine fetal lung maturity. Both lecithin and sphingomyelin are lung surfactants that are present in increasing amounts in the maturing fetus, though past week 33, sphingomyelin levels remain relatively constant.
The surfactant–albumin ratio is a test for assessing fetal lung maturity. [1] The test, though no longer commercially available, used an automatic analyzer to measure the polarized fluorescent light emitted from a sample of amniotic fluid that had been challenged with a fluorescent probe that interacted competitively with both lecithin (phosphatidylcholine) and albumin in such a way that ...
The lamellar body count is a test for assessing fetal lung maturity. [1] [2] References 3. Laboratory Testing To Assess Fetal Lung Maturity Darlynn J. Lafler, BS MT ...
In pregnancies of longer than 30 weeks, the fetal lung maturity may be tested by sampling the amount of surfactant in the amniotic fluid by amniocentesis, wherein a needle is inserted through the mother's abdomen and uterus. Several tests are available that correlate with the production of surfactant.
Annuities let you convert your savings into steady monthly payments that can last your lifetime, but come with high fees and complicated rules.
Phosphatidylglycerol is a glycerophospholipid found in pulmonary surfactant [1] and in the plasma membrane where it directly activates lipid-gated ion channels. The general structure of phosphatidylglycerol consists of a L-glycerol 3-phosphate backbone ester-bonded to either saturated or unsaturated fatty acids on carbons 1 and 2.